Home/Filings/4/0001209191-20-005187
4//SEC Filing

Maloberti Renaud Bertrand 4

Accession 0001209191-20-005187

CIK 0001681682other

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 5:03 PM ET

Size

5.4 KB

Accession

0001209191-20-005187

Insider Transaction Report

Form 4
Period: 2020-01-25
Maloberti Renaud Bertrand
Chief Commercial Officer
Transactions
  • Award

    Stock Options

    2020-01-25+20,00020,000 total
    Exercise: $1.71Exp: 2030-01-25Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]This stock option grant becomes exercisable in three equal annual installments beginning January 25, 2021.

Issuer

ENDRA Life Sciences Inc.

CIK 0001681682

Entity typeother

Related Parties

1
  • filerCIK 0001744025

Filing Metadata

Form type
4
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 5:03 PM ET
Size
5.4 KB